Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$25.55

0.34 (1.35%)

17:01
08/08/17
08/08
17:01
08/08/17
17:01

Myriad Genetics sees FY18 adjusted EPS $1.00-$1.85, consensus $1.01

Sees FY18 revenue $750M-$777M, consensus $764.72M.

  • 08

    Aug

MYGN Myriad Genetics
$25.55

0.34 (1.35%)

06/29/17
JPMS
06/29/17
NO CHANGE
Target $16
JPMS
Underweight
JPMorgan keeps Underweight rating, $16 target on Myriad Genetics
With the shares up 30% over the past month, JPMorgan analyst Tycho Peterson maintains an Underweight rating on Myriad Genetics with a $16 price target. While the company's pipeline "intriguing," it is not enough to offset a continued decline in the core hereditary cancer business, Peterson tells investors in a research note. He believes near-term catalysts could drive the stock "meaningfully higher or lower," and highlights the FY18 guidance in the Q4 earnings report as being the most significant upcoming event.
04/05/17
04/05/17
NO CHANGE

Myriad Genetics publishes pivotal studies for myPath melanoma test
Myriad Genetics has published the third clinical validation study and second clinical utility study for its myPath Melanoma test, which completes the reimbursement dossier for the product. The company will submit the reimbursement dossier to Medicare and private insurers three months earlier than expected. myPath Melanoma is an objective genetic test that measures 23 genes to help differentiate malignant melanoma from benign lesions. The third clinical validation was published in the journal Cancer Epidemiology, Biomarkers & Prevention. The study assessed the performance of the myPath Melanoma test in an independent cohort of 182 patients with melanocytic lesions against clinically proven outcomes. The results showed that the myPath Melanoma test had an overall diagnostic accuracy of 95% to effectively differentiate melanoma from benign lesions. The second clinical utility study was designed to evaluate changes in real world patient management based upon the myPath Melanoma test result. Results showed a 71% change in patient management from pre-test recommendations and an 81% reduction in biopsy site re-excisions for patients with a benign test result.
03/28/17
DBAB
03/28/17
NO CHANGE
Target $15
DBAB
Sell
Zejula label removes upside catalyst for Myriad, says Deutsche Bank
Deutsche Bank analyst Dan Leonard says FDA approval of Tesaro's (TSRO) Zejula, with a "broad rather than biomarker-limited label," removes one potential upside catalyst for Myriad Genetics (MYGN). While some investors are surprised by the broad label, many had already discounted the possibility of a label that limited usage to biomarker positive patients, which would have benefited test-supplier Myriad, Leonard tells investors in a research note. The analyst keeps a Sell rating on Myriad with a $15 price target.
03/13/17
SPHN
03/13/17
UPGRADE
SPHN
Overweight
Myriad Genetics upgraded to Overweight from Equal Weight at Stephens

TODAY'S FREE FLY STORIES

MU

Micron

$45.74

2.16 (4.96%)

12:09
09/18/18
09/18
12:09
09/18/18
12:09
Technical Analysis
Technical Take: Micron at highs of session on buyback speculation »

RBC Capital issued a note…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

SCOR

comScore

$19.68

0.19 (0.97%)

12:09
09/18/18
09/18
12:09
09/18/18
12:09
Hot Stocks
comScore Canada GM Brent Bernie leaving, Bryan Segal assuming role »

comScore announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

SPWR

SunPower

$7.26

0.68 (10.33%)

12:08
09/18/18
09/18
12:08
09/18/18
12:08
Periodicals
Breaking Periodicals news story on SunPower »

SunPower CEO:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$18.35

7.95 (76.44%)

, MDGL

Madrigal Pharmaceuticals

$199.85

-28.82 (-12.60%)

12:08
09/18/18
09/18
12:08
09/18/18
12:08
Recommendations
Viking Therapeutics, Madrigal Pharmaceuticals analyst commentary  »

Viking NAFLD data beat…

VKTX

Viking Therapeutics

$18.35

7.95 (76.44%)

MDGL

Madrigal Pharmaceuticals

$199.85

-28.82 (-12.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 01

    Oct

QCOM

Qualcomm

$75.24

1.99 (2.72%)

, AVGO

Broadcom

$239.98

6.88 (2.95%)

12:08
09/18/18
09/18
12:08
09/18/18
12:08
Periodicals
Qualcomm in discussions to add 'at least' two directors to board, Reuters says »

Qualcomm (QCOM) is…

QCOM

Qualcomm

$75.24

1.99 (2.72%)

AVGO

Broadcom

$239.98

6.88 (2.95%)

NXPI

NXP Semiconductors

$91.06

0.91 (1.01%)

AAPL

Apple

$219.48

1.62 (0.74%)

MDLZ

Mondelez

$43.48

-0.24 (-0.55%)

LRCX

Lam Research

$154.85

2.72 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 28

    Oct

TECH

Bio-Techne

$197.07

0.27 (0.14%)

12:04
09/18/18
09/18
12:04
09/18/18
12:04
Hot Stocks
Bio-Techne reports publication of data showing additional validation of EPI test »

Bio-Techne announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TSLA

Tesla

$287.07

-7.71 (-2.62%)

12:03
09/18/18
09/18
12:03
09/18/18
12:03
Technical Analysis
Technical Take: Tesla drops sharply on report of DOJ criminal probe »

The shares have spiked…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

VKTX

Viking Therapeutics

$18.62

8.22 (79.04%)

, MDGL

Madrigal Pharmaceuticals

$199.75

-28.92 (-12.65%)

12:03
09/18/18
09/18
12:03
09/18/18
12:03
Recommendations
Viking Therapeutics, Madrigal Pharmaceuticals analyst commentary  »

H.C. Wainwright boosts…

VKTX

Viking Therapeutics

$18.62

8.22 (79.04%)

MDGL

Madrigal Pharmaceuticals

$199.75

-28.92 (-12.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 01

    Oct

A

Agilent

$68.76

-0.32 (-0.46%)

12:03
09/18/18
09/18
12:03
09/18/18
12:03
Hot Stocks
Agilent files new complaint against Twist Bioscience regarding stolen documents »

Agilent Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

SEAS

SeaWorld

$31.13

-0.05 (-0.16%)

12:01
09/18/18
09/18
12:01
09/18/18
12:01
Periodicals
Breaking Periodicals news story on SeaWorld »

SeaWorld sued by SEC for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBEV

New Age Beverages

$2.57

0.26 (11.26%)

12:01
09/18/18
09/18
12:01
09/18/18
12:01
Recommendations
New Age Beverages analyst commentary  »

New Age Beverages to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$12.61

-0.105 (-0.83%)

12:00
09/18/18
09/18
12:00
09/18/18
12:00
Options
Notable buying in GE short-term puts as shares see relative weakness »

Notable buying in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

NEE

NextEra Energy

$173.18

-0.67 (-0.39%)

11:56
09/18/18
09/18
11:56
09/18/18
11:56
Conference/Events
NextEra Energy management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 11

    Nov

GIS

General Mills

$44.08

-3.69 (-7.72%)

, KHC

Kraft Heinz

$56.96

-1.39 (-2.38%)

11:56
09/18/18
09/18
11:56
09/18/18
11:56
Hot Stocks
General Mills plunges after reporting North America sales decline »

Shares of General Mills…

GIS

General Mills

$44.08

-3.69 (-7.72%)

KHC

Kraft Heinz

$56.96

-1.39 (-2.38%)

SJM

J.M. Smucker

$110.00

-1.66 (-1.49%)

CPB

Campbell Soup

$39.92

-1.04 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 20

    Sep

  • 24

    Sep

  • 09

    Oct

  • 28

    Oct

11:55
09/18/18
09/18
11:55
09/18/18
11:55
General news
Treasury's $40 B 4-week bill auction was strong on several counts »

Treasury's $40 B…

11:55
09/18/18
09/18
11:55
09/18/18
11:55
Conference/Events
Stephens retail/hardlines analyst to hold luncheon meeting »

Retail/Hardlines Analyst…

11:55
09/18/18
09/18
11:55
09/18/18
11:55
Conference/Events
Jefferies strategy and tech team to hold a luncheon meeting »

Best Ideas & Strategy…

BABA

Alibaba

$157.03

-1.73 (-1.09%)

11:54
09/18/18
09/18
11:54
09/18/18
11:54
Recommendations
Alibaba analyst commentary  »

SunTrust incrementally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 28

    Oct

TSLA

Tesla

$301.59

6.81 (2.31%)

11:50
09/18/18
09/18
11:50
09/18/18
11:50
Hot Stocks
Tesla said to face criminal probe alongside civil inquiry »

Tesla, which is already…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

SGMS

Scientific Games

$26.65

1.775 (7.14%)

11:50
09/18/18
09/18
11:50
09/18/18
11:50
Options
Longer-term call buying in Scientific Games as shares spike off 52-week lows »

Longer-term call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$75.32

2.07 (2.83%)

11:47
09/18/18
09/18
11:47
09/18/18
11:47
Periodicals
Breaking Periodicals news story on Qualcomm »

Qualcomm in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$302.10

7.32 (2.48%)

11:44
09/18/18
09/18
11:44
09/18/18
11:44
Periodicals
Tesla to face criminal probe from DOJ over Musk tweet, Bloomberg says »

The DOJ is conducting an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

GGB

Gerdau

$3.95

0.145 (3.81%)

11:40
09/18/18
09/18
11:40
09/18/18
11:40
Options
Bullish flow in Gerdau as shares see strength »

Bullish flow in Gerdau as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
09/18/18
09/18
11:40
09/18/18
11:40
General news
Euro$ interest rate futures are mixed »

Euro$ interest rate…

CHEK

Check-Cap

$3.60

0.15 (4.35%)

11:39
09/18/18
09/18
11:39
09/18/18
11:39
Hot Stocks
Check-Cap granted FCC equipment authorization for C-Scan Cap transceiver »

The FCC granted equipment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.